Protease Inhibitors: General Research
- Protease Inhibitors in Children: Combination Therapy Reduced Death by Two Thirds (November 23, 2001)
To read PDF, click here.
In AIDS Treatment News, from AIDS Treatment News
On TheBodyPRO.com
- The Impact of First Line Therapies on Lipid Metabolism: The FRAMS Data (October 28, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from TheBodyPRO.com
- Simplification of Protease Inhibitor-Containing HAART Regimen With Abacavir Maintains Viral Suppression and Favorable Adherence in HIV-1 Infected Adults (October 27, 2001)
In 39th Annual Meeting of the Infectious Diseases Society of America, from TheBodyPRO.com
- A Retrospective Cohort Study of the Durability of Antiretroviral Therapy Using Nevirapine versus Antiretroviral Therapy Using Protease Inhibitors (October 27, 2001)
In 39th Annual Meeting of the Infectious Diseases Society of America, from TheBodyPRO.com
- Comparison of QD Protease Inhibitors (PIs): Estimated Cmin/IC50 (IQ) After Missed Dose Shows Agenerase Advantage (July 9, 2001)
In The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Experimental PI Drugs (Spring 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Do Protease Inhibitors Increase the Risk for Coronary Heart Disease Among HIV-Positive Patients-Follow-Up Through June 2000 (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Efficacy and Safety of Switch to 3TC 300 mg QD vs. Continued 3TC 150 mg BID in Subjects with Virologic Suppression on Stable 3TC/d4T/PI Therapy (COLA4005): Final 24-Week Results (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Incidence and Predictors of Clinical Progression Among HIV-Infected Patients Experiencing Virologic Failure of Protease Inhibitor-Based Regimens (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Plasma Trough Levels Correlate with Distinct Genetic Mechanisms During the Development of Amprenavir Resistance (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- More Data on the Comparative Efficacy of Protease Inhibitors Versus Non-nukes (October 10, 2000)
STEP's coverage of the 40th ICAAC Conference.
In STEP Ezine, from Seattle Treatment Education Project
- New Protease Inhibitors (October 2000)
From Project Inform
- Efficacy of Protease Inhibitor Switching to Nevirapine in Patients on HAART with Undetectable Viral Load (July 12, 2000)
In The XIII International AIDS Conference, from TheBodyPRO.com
- Sustained Virologic Suppression in Subjects Switched From Protease Inhibitors to Nevirapine (July 12, 2000)
In The XIII International AIDS Conference, from TheBodyPRO.com
- What's This About P-Glycoprotein? (July 2000)
In TAGline, from Treatment Action Group
- Simpler Is Better, So Far (Winter 1999/2000)
To PI-spare or not to PI-spare. Can't we just call it a draw?.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Blood Lipid Treatment and Switching Drugs for Lipodystrophy (May 1999)
In Body Positive, from Body Positive
- HAART, Dyslipidemia, and Hyperglycemia (April 22-25, 1999)
In The 3rd International Conference on Nutrition and HIV Infection, from TheBodyPRO.com
- The Changing Face of Malnutrition and HIV (April 22-25, 1999)
In The 3rd International Conference on Nutrition and HIV Infection, from TheBodyPRO.com
- Quantifying Abnormalities Associated with Fat Redistribution Syndrome (April 22-25, 1999)
In The 3rd International Conference on Nutrition and HIV Infection, from TheBodyPRO.com
- Growth Hormone (rhGH) and Fat Redistribution Syndrome (April 22-25, 1999)
In The 3rd International Conference on Nutrition and HIV Infection, from TheBodyPRO.com
|
Advertisement
|
Email
Glossary
